Carbapenem Resistant Gram-Negative Pathogens—a Comprehensive Approach to Acinetobacter, Pseudomonas, Enterobacteriaceae, and Stenotrophomonas: A Global Healthcare Threat

Dear Colleagues,

Carbapenem-resistant bacteria are recognized as a major global healthcare threat. The World Health Organization’s (WHO) published list of ‘priority pathogens’ highlights carbapenem-resistance in Acinetobacter baumannii, Pseudomonas aeruginosa, and Enterobacteriaceae as three critical priority level 1 threats. These pathogens, along with Stenotrophomonas maltophilia, are a challenge for physicians with respect to establishing a timely diagnosis and an even greater challenge in determining an optimal treatment strategy. This Special Issue seeks to provide a comprehensive framework in all aspects of epidemiology, the integration of antibiotic stewardship and rapid diagnostics, and therapeutic approaches for these carbapenem-resistant bacterial pathogens. Research focused on the efficacy and utilization of novel treatment strategies and the integration of newly available therapeutic agents are of particular interest.

Dr. Darren W. Wong
Dr. Paul F. Riska
Guest Editors

Manuscript Submission Information

Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 250 words) can be sent to the Editorial Office for assessment.

Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Antibiotics is an international peer-reviewed open access monthly journal published by MDPI.

Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2900 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.